Hashimoto T, Toyoda Y, Matsukawa H, Tsuriya Y, Yanagihara Y
Research Institute, Wakamoto Pharmaceutical Co., Ltd.
Arerugi. 1992 Sep;41(9):1430-3.
To determine whether tazanolast inhibits airway hyperresponsiveness, we studied the effect of this drug on platelet activating factor (PAF)-induced airway hyperresponsiveness in guinea pigs. Inhalation of PAF (1 microgram/ml) caused significant airway hyperresponsiveness to acetylcholine (p < 0.01) or histamine (p < 0.05). Pretreatment with tazanolast (30-300 mg/kg) produced a dose-dependent inhibition of airway hyperresponsiveness induced by PAF inhalation, and significant inhibition (p < 0.05) was obtained with the drug (300 mg/kg). Aspirin also inhibited PAF-induced airway hyperresponsiveness, while tranilast produced hardly any inhibition. From these results, it is suggested that tazanolast is effective in inhibiting airway hyperresponsiveness.
为了确定他扎诺酯是否能抑制气道高反应性,我们研究了该药物对豚鼠血小板活化因子(PAF)诱导的气道高反应性的影响。吸入PAF(1微克/毫升)会导致对乙酰胆碱(p < 0.01)或组胺(p < 0.05)的显著气道高反应性。用他扎诺酯(30 - 300毫克/千克)预处理可产生剂量依赖性地抑制PAF吸入诱导的气道高反应性,且该药物(300毫克/千克)可产生显著抑制作用(p < 0.05)。阿司匹林也能抑制PAF诱导的气道高反应性,而曲尼司特几乎没有抑制作用。从这些结果表明,他扎诺酯在抑制气道高反应性方面是有效的。